Is your child currently experiencing CD flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce cramping, reduced appetite, constant need to poop, malnutrition, and/or anemia associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease (CD) research to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or Crohn’s disease (CD) (including associated symptoms such as weight loss, growth failure, cramps, frequent fevers and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce stomach pain, mouth sores, abdominal pain, chronic fatigue, and/or canker sores associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children and teens 2–17 years of age to join a medical research study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or Crohn’s (including associated symptoms such as chronic diarrhea, fistula, abdominal pain, malnutrition and/or joint pain), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing UC flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce abdominal pain or cramping, inflammation of the bowel or intestine, diarrhea, malnutrition, and/or eye pain associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for teen to join a CD study to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or IBD (including associated symptoms such as diarrhea with blood, failure to thrive, rectal pain, chronic fatigue and/or canker sores), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing moderate to severe UC flare-ups? Local CD clinical research is testing a potential new medication to see if it may reduce cramps, failure to thrive, cramps, chronic fatigue, and/or liver disease associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the CD clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for young people 2 to 17 years of age to join a Crohn’s disease clinical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Crohn’s (including associated symptoms such as diarrhea with pus, abdominal cramps, abdominal pain, frequent fevers and/or liver disease), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce stomach pain, persistent diarrhea, rectal pain, weight loss, and/or eye pain associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for young people 2–17 years old to join a Crohn’s disease (CD) clinical research to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or CD and UC (including associated symptoms such as recurrent diarrhea, abdominal cramps, abdominal pain, malnutrition and/or liver disease), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.